Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  UnitedHealth Group Inc    UNH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales110 618122 489130 474153 538176 474189 578
Operating income (EBITDA)10 56310 99811 75212 79314 80216 025
Operating profit (EBIT)9 2549 62310 27411 20812 91314 429
Pre-Tax Profit (EBT)8 6228 915----
Net income5 5265 6255 6196 0886 9598 024
EPS ( $)5,285,505,706,327,308,54
Dividend per Share ( $)0,801,051,411,571,651,31
Yield0,66%0,86%1,16%1,29%1,36%1,07%
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt8 3487 6478 17010 3407 1525 334
Finance------
Operating income (EBITDA)10 56310 99811 75212 79314 80216 025
Leverage
(Debt/EBITDA)
0,79x0,70x0,70x0,81x0,48x0,33x
Capital Expenditure1 0701 1611 4471 5751 6681 595
Book Value Per Share (BVPS)30,6 $32,5 $33,7 $38,6 $42,5 $46,0 $
Cash Flow per Share6,84 $6,83 $8,16 $8,36 $9,90 $10,3 $
Announcement Date01/17/2013
11:00am
01/16/2014
11:00am
01/21/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 115 675 M$ -
Entreprise Value (EV) 126 015 M$ 122 828 M$
Valuation 2015e 2016e
PER (Price / EPS) 19,2x 16,7x
Capitalization / Revenue 0,75x 0,66x
EV / Revenue 0,82x 0,70x
EV / EBITDA 9,85x 8,30x
Yield (DPS / Price) 1,29% 1,36%
Price to book (Price / BVPS) 3,15x 2,86x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 7,30% 7,32%
operating Leverage (Delta EBIT / Delta Sales) 0,51x 1,02x
Net Margin (Net Profit / Revenue) 3,96% 3,94%
ROA (Net Profit / Asset) 6,60% 7,15%
ROE (Net Profit / Equities) 17,2% 18,0%
Rate of Dividend 24,9% 22,7%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   1,03% 0,95%
Cash Flow / Sales (Taux d'autofinancement) 5,18% 5,34%
Capital Intensity (Assets / Sales) 0,60x 0,55x
Financial Leverage (Net Debt / EBITDA) 0,81x 0,48x
Price Earning Ratio
EPS & Dividend